You are here
Generic Version of Celexa Now Available
February 4, 2005
PITTSBURGH, Feb. 4 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE:MYL) today announced that the U.S. Food and Drug Administration has granted final approval for Mylan Pharmaceuticals Inc.'s Abbreviated New Drug Application for Citalopram Hydrobromide Tablets, 10 mg, 20 mg and 40 mg. Citalopram Hydrobromide is the generic version of Forest Laboratories Inc.'s Celexa(R).
The product will be shipped immediately.
Source: Mylan Laboratories
Citrus, Berries, Broccoli Reduce Risk of Cancer and CVD
Changes in Antibiotic Recommendations for Children
Influences Gene Involved in Circadian Rhythms
Connection May Be Hormonal
‘The Perfect Drug for Trauma-Focused Psychotherapy’
Triggers the Body’s Own Natural Blood Flow Regulation
Inrebic Reduces Symptoms by 50% in Some Patients
Novel Catheter-based Technology for Treating Acute Ischemic Stroke
Decision supported by data from more than 4,000 patients